Adaptimmune Therapeutics plc (ADAP)
USD 0.61
(1.1%)
USD 0.61
(1.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 60.28 Million | 27.14 Million | 6.14 Million | 3.95 Million | 1.12 Million | 59.5 Million |
| Cost of Revenue | 9.85 Million | 127.72 Million | 111.09 Million | 91.56 Million | 97.5 Million | - |
| Gross Profit | 50.42 Million | -100.57 Million | -104.94 Million | -87.61 Million | -96.37 Million | 59.5 Million |
| Operating Expenses | 200.02 Million | 191.11 Million | 168.39 Million | 137.36 Million | 140.89 Million | 141.87 Million |
| Selling, General and Administrative Expenses | 73.51 Million | 63.38 Million | 57.3 Million | 45.79 Million | 43.39 Million | 43.6 Million |
| Research and Development Expenses | 126.5 Million | 127.72 Million | 111.09 Million | 91.56 Million | 97.5 Million | 98.26 Million |
| Other Expenses | - | -536 Thousand | 3.85 Million | 1.16 Million | 75 Thousand | -15.5 Million |
| Cost and Expenses | 200.02 Million | 191.11 Million | 168.39 Million | 137.36 Million | 140.89 Million | 141.87 Million |
| Operating Income | -138.03 Million | -163.96 Million | -162.24 Million | -133.4 Million | -139.77 Million | -82.36 Million |
| Interest Expense | - | - | - | - | - | 376 Thousand |
| Income Tax Expense | 1.33 Million | 2.49 Million | 791 Thousand | 162 Thousand | 242 Thousand | 497 Thousand |
| Earnings before Tax | -112.53 Million | -162.95 Million | -157.29 Million | -129.93 Million | -136.92 Million | -95.01 Million |
| Net Income | -113.87 Million | -165.45 Million | -158.09 Million | -130.09 Million | -137.16 Million | -95.51 Million |
| Earnings Per Share Basic | -0.57 | -1.03 | -1.01 | -0.91 | -1.31 | -0.98 |
| Earnings Per Share Diluted | -0.57 | -1.03 | -1.01 | -0.91 | -1.31 | -0.98 |
| Weighted Average Shares Outstanding | 201.07 Million | 161.2 Million | 155.8 Million | 142.46 Million | 104.96 Million | 97.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 201.07 Million | 161.2 Million | 155.8 Million | 142.46 Million | 104.96 Million | 97.38 Million |
| Gross Margin | 0.84 | -3.70 | -17.07 | -22.13 | -85.90 | 1.00 |
| EBIT Margin | -2.13 | -5.82 | -25.32 | -31.79 | -117.43 | -1.25 |
| Profit Margin | -1.89 | -6.09 | -25.71 | -32.87 | -122.25 | -1.61 |
| EBITDA | -128.19 Million | -155.59 Million | -155.67 Million | -125.81 Million | -131.75 Million | -74.55 Million |
| Earnings Before Tax Margin | -2.29 | -6.04 | -26.39 | -33.71 | -124.57 | -1.38 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 128.37 Million | 5.67 Million | 60.51 Million | 233 Thousand | 7.31 Million | 5.13 Million |
| Cost of Revenue | 2.74 Million | 2.82 Million | 9.85 Million | 2.87 Million | 2.87 Million | 2.23 Million |
| Gross Profit | 125.62 Million | 2.84 Million | 50.65 Million | -2.64 Million | 4.44 Million | 2.89 Million |
| Operating Expenses | 59.22 Million | 54.93 Million | 188.42 Million | 51.37 Million | 53.95 Million | 50.03 Million |
| Selling, General and Administrative Expenses | 16.35 Million | 19.73 Million | - | 14.15 Million | 16.16 Million | 20.07 Million |
| Research and Development Expenses | 42.86 Million | 35.2 Million | - | 37.22 Million | 37.78 Million | 29.96 Million |
| Other Expenses | 497 Thousand | -61 Thousand | -807 Thousand | -313 Thousand | -324 Thousand | 501 Thousand |
| Cost and Expenses | 61.96 Million | 54.93 Million | 198.28 Million | 54.25 Million | 53.95 Million | 50.03 Million |
| Operating Income | 66.4 Million | -49.26 Million | -137.76 Million | -54.01 Million | -46.28 Million | -44.9 Million |
| Interest Expense | 526 Thousand | - | - | 5000.00 | - | - |
| Income Tax Expense | -1.85 Million | -526 Thousand | -14.26 Million | -4.38 Million | -687 Thousand | 680 Thousand |
| Earnings before Tax | 67.74 Million | -47.97 Million | -128.57 Million | -52.72 Million | -44.91 Million | -20.7 Million |
| Net Income | 69.52 Million | -48.5 Million | -114.31 Million | -48.33 Million | -45.6 Million | -21.38 Million |
| Earnings Per Share Basic | 0.27 | -0.20 | - | -0.21 | -0.20 | -0.12 |
| Earnings Per Share Diluted | 0.27 | -0.20 | - | -0.21 | -0.20 | -0.12 |
| Weighted Average Shares Outstanding | 255.58 Million | 241.87 Million | 201.07 Million | 227.11 Million | 226.3 Million | 184.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 259.86 Million | 241.87 Million | 201.07 Million | 227.11 Million | 226.3 Million | 184.69 Million |
| Gross Margin | 0.98 | 0.50 | 0.84 | -11.34 | 0.61 | 0.56 |
| EBIT Margin | 0.54 | -8.68 | - | -219.49 | -6.32 | -12.64 |
| Profit Margin | 0.54 | -8.54 | -1.89 | -207.43 | -6.23 | -4.17 |
| EBITDA | 69.15 Million | -49.26 Million | - | -51.14 Million | -46.28 Million | -64.83 Million |
| Earnings Before Tax Margin | 0.52 | -8.68 | -2.28 | -231.83 | -6.32 | -8.75 |
BENH
2115
AWZ
DUOT
8013
1459